Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorErrazquin, Ricardo
dc.contributor.authorPage, Angustias
dc.contributor.authorSuñol, Anna
dc.contributor.authorSegrelles, Carmen
dc.contributor.authorCarrasco Lopez, Estela
dc.contributor.authorPeral, Jorge
dc.contributor.authorBalmaña, Judith
dc.date.accessioned2023-06-06T08:29:52Z
dc.date.available2023-06-06T08:29:52Z
dc.date.issued2022-11
dc.identifier.citationErrazquin R, Page A, Suñol A, Segrelles C, Carrasco E, Peral J, et al. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. Oral Oncol. 2022 Nov;134:106184.
dc.identifier.issn1368-8375
dc.identifier.urihttps://hdl.handle.net/11351/9668
dc.descriptionHead and neck squamous cell carcinoma; Mouse model; Oral mucosa
dc.description.abstractFanconi anemia (FA) patients frequently develop oral squamous cell carcinoma (OSCC). This cancer in FA patients is diagnosed within the first 3–4 decades of life, very often preceded by lesions that suffer a malignant transformation. In addition, they respond poorly to current treatments due to toxicity or multiple recurrences. Translational research on new chemopreventive agents and therapeutic strategies has been unsuccessful partly due to scarcity of disease models or failure to fully reproduce the disease. Here we report that Fanca gene knockout mice (Fanca-/-) frequently display pre-malignant lesions in the oral cavity. Moreover, when these animals were crossed with animals having conditional deletion of Trp53 gene in oral mucosa (K14cre;Trp53F2-10/F2-10), they spontaneously developed OSCC with high penetrance and a median latency of less than ten months. Tumors were well differentiated and expressed markers of squamous differentiation, such as keratins K5 and K10. In conclusion, Fanca and Trp53 genes cooperate to suppress oral cancer in mice, and Fanca-/-;K14cre;Trp53F2-10/F2-10 mice constitute the first animal model of spontaneous OSCC in FA.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesOral Oncology;134
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAnèmia de Fanconi
dc.subjectRatolins
dc.subjectBoca - Càncer - Diagnòstic
dc.subject.meshFanconi Anemia
dc.subject.meshMice
dc.subject.meshMouth Neoplasms
dc.titleDevelopment of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.oraloncology.2022.106184
dc.subject.decsanemia de Fanconi
dc.subject.decsratones
dc.subject.decsneoplasias de la boca
dc.relation.publishversionhttps://doi.org/10.1016/j.oraloncology.2022.106184
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Errazquin R] Research Institute Hospital 12 de Octubre (imas12), University Hospital “12 de Octubre”, Madrid, Spain. [Page A, Segrelles C] Research Institute Hospital 12 de Octubre (imas12), University Hospital “12 de Octubre”, Madrid, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Madrid, Spain. [Suñol A, Carrasco E, Balmaña J] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Peral J] Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Madrid, Spain
dc.identifier.pmid36191479
dc.identifier.wos000933965200007
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record